Mingjin Yan

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial

Joel E. Gallant, Eric S. Daar, François Raffi et al. · The Lancet HIV · 2016 · 165 citations

Treatment And Prevention, Medicine, Antiviral Drug Development +10

Determining the Number of Clusters Using the Weighted Gap Statistic

Mingjin Yan, Keying Ye · Biometrics · 2007 · 155 citations

Cluster Computing, Engineering, Cluster Analysis +16

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy

Anthony Mills, Gordon Crofoot, Cheryl McDonald et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2015 · 139 citations

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

François Raffi, Chloe Orkin, Amanda Clarke et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 83 citations · Full text

Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial

Leszek Bidzan, Atul R. Mahableshwarkar, Paula L. Jacobsen et al. · European Neuropsychopharmacology · 2012 · 72 citations

Lu Aa21004, Psychiatry, Comorbid Psychiatric Disorder +11